Scotts MiracleGro (SMG)
(Delayed Data from NYSE)
$70.82 USD
+1.06 (1.52%)
Updated May 14, 2024 04:00 PM ET
After-Market: $70.80 -0.02 (-0.03%) 6:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$70.82 USD
+1.06 (1.52%)
Updated May 14, 2024 04:00 PM ET
After-Market: $70.80 -0.02 (-0.03%) 6:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Zacks News
5 Must-See Earnings Charts This Week
by Tracey Ryniec
Wellness and lifestyle companies have been front and center thanks to Millennial demands for experiences. These 5 companies are some of the top names.
Scotts Miracle-Gro to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Sunlight Supply acquisition, higher promotional activities and increased retail support are likely to reflect in Scotts Miracle-Gro's (SMG) Q4 results.
Scotts Miracle-Gro (SMG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Scotts Miracle-Gro (SMG) closed at $98.55 in the latest trading session, marking a -0.1% move from the prior day.
Zacks.com featured highlights include: FTI Consulting, Scotts Miracle-Gro and PennyMac Financial Services
by Zacks Equity Research
Zacks.com featured highlights include: FTI Consulting, Scotts Miracle-Gro and PennyMac Financial Services
Earnings Preview: Scotts Miracle-Gro (SMG) Q4 Earnings Expected to Decline
by Zacks Equity Research
Scotts (SMG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Stocks With Momentum Anomaly to Enhance Portfolio Returns
by Zacks Equity Research
Momentum stocks don't usually offer attractive entry points, as the trend established by these continues for some time. So, any major reversal in trend could offer a solid buying opportunity.
Scotts Miracle-Gro Enters Oversold Territory
by Zacks Equity Research
The Scotts Miracle-Gro has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
B2Gold Concludes Sale of Nicaragua Assets to Calibre Mining
by Zacks Equity Research
B2Gold (BTG) sells its Nicaraguan assets to Calibre Mining and now holds around 30% of Calibre's shares.
Vale Q3 Iron Ore Output Up 35% Q/Q, To Recover 50 Mt by 2021
by Zacks Equity Research
Vale S.A's (VALE) iron ore production numbers in the third quarter exhibit a sequential improvement as mines shut in the wake of the Brumadinho disaster resumed operations.
Here's Why You Should Add Scotts Miracle-Gro (SMG) Stock Now
by Zacks Equity Research
Upbeat view and bright prospects in the Hawthorne unit makes Scotts Miracle-Gro (SMG) an attractive investment option.
Mosaic to Temporarily Curtail Production at Esterhazy Mine
by Zacks Equity Research
Mosaic (MOS) plans to temporarily curb production at its Esterhazy potash mine but assures that this will not hinder development at the Esterhazy mine K3 project.
Fertilizers Industry Outlook: Near-Term Prospects Bleak
by Nilanjan Gupta
Investors may want to consider these fertilizers stocks amid a challenging environment.
Scotts Miracle-Gro Upsizes & Prices Senior Notes Due 2029
by Zacks Equity Research
Scotts Miracle-Gro (SMG) is expected to utilize the net proceeds from the offering to redeem all of its outstanding 6% senior notes due 2023.
Cannabis Industry to Scale New Highs Amid Legalization Woes
by Nilanjan Gupta
Legalization will likely drive commercial distribution of cannabis and boost growth of companies operating in this space.
Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?
by Benjamin Rains
Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?
The Zacks Analyst Blog Highlights: FTI, Keysight, NewMarket, Pilgrim's Pride and The Scotts Miracle-Gro
by Zacks Equity Research
The Zacks Analyst Blog Highlights: FTI, Keysight, NewMarket, Pilgrim's Pride and The Scotts Miracle-Gro
5 Top Growth Stocks for September to Ride on Market Rally
by Nalak Das
The U.S. economy is likely to maintain its long-term growth albeit at a slow pace. Several stimulus measures across the globe will also help the U.S. economy to remain stable.
Scotts Miracle-Gro (SMG) Stock Up 16% in 3 Months: Here's Why
by Zacks Equity Research
Better-than-expected Q3 results, upbeat view as well as bright prospects in the Hawthorne unit are driving Scotts Miracle-Gro's (SMG) shares.
Scotts (SMG) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Scotts (SMG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Why Scotts Miracle-Gro is Worth Adding to Your Portfolio Now
by Zacks Equity Research
Strong Q3 results, upward estimate revision and upbeat outlook makes Scotts Miracle-Gro (SMG) an appropriate investment option at the moment.
Delta and Scotts Miracle Grow are Aggressive Growth Stocks
by Brian Bolan
A look at two stocks for your aggressive growth stock radar screen
Scotts Miracle-Gro (SMG) Tops Q3 Earnings & Sales Estimates
by Zacks Equity Research
The Sunlight Supply acquisition drives Scotts Miracle-Gro's (SMG) Hawthorne segment in Q3.
Why Scotts Miracle-Gro (SMG) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Scotts Miracle-Gro (SMG) have what it takes? Let's find out.
Scotts Miracle-Gro (SMG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of 14.76% and 9.81%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Will Hawthorne Drive Scotts Miracle-Gro's (SMG) Q3 Earnings?
by Zacks Equity Research
Scotts Miracle-Gro (SMG) is witnessing strong growth in the Hawthorne unit, which will likely continue in Q3.